Related Experiment Video
Updated: Aug 9, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
[Use of new antidepressive agents in general practice]
G Mouland1, B Bratland, M Fagan
1Legegruppen Grandgården, Arendal.
Abstract:
There is much discussion about the use of the new antidepressant drugs. Some advocate a more liberal use while others criticize overprescribing. Our study examines the indication, dosage and length of treatment in five family practices. Records of 208 patients prescribed one of three new antidepressants in 1995 were reviewed. 90% had depression or anxiety while 10% received medication for pain or for other symptoms. Dosage and median length of treatment were in accordance with recommended guidelines. However, a number of patients discontinue their medication within a month of start of treatment. The study did not examine the reason for this, but side effects or lack of effect are possible explanations. 36 patients were treated for a year or longer and we raise the question whether abstinence-like symptoms or the physicians prescribing practice can explain this finding. The article also examines the increased sale of the new antidepressants in Norway and in Aust-Agder county specifically, the county in Norway with the largest per capita sale of these drugs.
More Related Videos
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
10:54Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
Published on: November 21, 2025
Related Concept Videos
Antidepressant Drugs: Overview
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Antidepressant Drugs: MAOIs and Other Agents
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Drug Therapy
Antianxiety Medications
Electroconvulsive Therapy